Skip to content

Clinical trials

Phase 3 Anemia, Sickle Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 3 Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20131
20152
20161
20182
20191
20212
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Active, not recruiting2
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Novo Nordisk A/S2
Pfizer2
Biossil Inc.1
Eli Lilly and Company1
Forma Therapeutics, Inc.1
GlycoMimetics Incorporated1
St. Justine's Hospital1
The Hospital for Sick Children1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell14
Vaso-Occlusive Crises4
Hematologic Diseases3
Thalassemia3
Anemia2
Genetic Diseases, Inborn2
Hemoglobinopathies2
Sickle Cell Trait2
Anemia, Diamond-Blackfan1
Anemia, Hemolytic1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.